CINECA IRIS Institutional Research Information System

MICHIELI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.226
EU - Europa 911
AS - Asia 741
AF - Africa 7
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 3.893
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.220
CN - Cina 368
IE - Irlanda 196
SG - Singapore 182
IT - Italia 153
FR - Francia 108
FI - Finlandia 101
UA - Ucraina 91
SE - Svezia 86
KR - Corea 81
DE - Germania 55
VN - Vietnam 50
GB - Regno Unito 39
PL - Polonia 24
ID - Indonesia 19
BE - Belgio 16
AT - Austria 12
IN - India 11
JP - Giappone 10
NL - Olanda 8
HK - Hong Kong 7
CA - Canada 6
SN - Senegal 5
BY - Bielorussia 4
GR - Grecia 4
RU - Federazione Russa 4
BR - Brasile 3
TH - Thailandia 3
AU - Australia 2
ES - Italia 2
EU - Europa 2
HU - Ungheria 2
IR - Iran 2
NG - Nigeria 2
PK - Pakistan 2
UZ - Uzbekistan 2
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
KZ - Kazakistan 1
LT - Lituania 1
MO - Macao, regione amministrativa speciale della Cina 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
TR - Turchia 1
TW - Taiwan 1
Totale 3.893
Salva come PNG Salva come JPEG
Città #
Chandler 283
Ann Arbor 237
Beijing 237
Dublin 196
Singapore 145
Santa Clara 124
Ashburn 90
Fairfield 90
Villeurbanne 81
Dearborn 80
Houston 65
Wilmington 59
Seattle 57
Princeton 56
Jacksonville 52
Medford 47
Columbus 45
Woodbridge 43
Nyköping 39
Torino 37
Dong Ket 34
Boston 33
Cambridge 32
Pisa 32
Warsaw 23
Guangzhou 19
Jakarta 19
Turin 19
Shanghai 12
Vienna 12
Brussels 11
San Diego 11
Milan 10
Nanjing 10
Des Moines 9
Redwood City 9
Boardman 8
Buffalo 8
Fremont 8
Washington 8
Norwalk 7
Hangzhou 6
Hefei 6
Jinan 6
Kunming 6
Munich 6
San Mateo 6
Seoul 6
Shenyang 6
Silver Spring 6
Falls Church 5
Gangnam-gu 5
Los Angeles 5
Nanchang 5
Napoli 5
Amsterdam 4
Dallas 4
Menlo Park 4
Phoenix 4
San Jose 4
Somerville 4
Verona 4
Bangkok 3
Chongqing 3
Cincinnati 3
Edinburgh 3
Padova 3
Seongdong-gu 3
São Paulo 3
Abuja 2
Antwerp 2
Anyang-si 2
Atlanta 2
Bhopal 2
Chennai 2
Duncan 2
Düsseldorf 2
Frederick 2
Glen Mills 2
Helsinki 2
Hirai 2
Hong Kong 2
Lachine 2
Liverpool 2
Manchester 2
Marseille 2
Nepi 2
New Haven 2
New York 2
Paris 2
Quevaucamps 2
Southend 2
Tokyo 2
Uiwang 2
Upper Marlboro 2
Westervoort 2
Xian 2
Zhengzhou 2
Acton 1
Almaty 1
Totale 2.585
Salva come PNG Salva come JPEG
Nome #
Targeted therapy by gene transfer of a monovalent antibody fragment against the Met oncogenic receptor. 209
ADAM17-dependent c-MET-STAT3 signaling mediates resistance to MEK inhibitors in KRAS mutant colorectal cancer. 161
Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody 160
Microenvironment-derived HGF overcomes genetically determined sensitivity to anti-MET drugs. 150
Four individually druggable MET hotspots mediate HGF-driven tumor progression. 148
Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth 136
Depleting MET-expressing tumor cells by ADCC provides a therapeutic advantage over inhibiting HGF/MET signaling 126
Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. 122
Stroma-derived HGF drives metabolic adaptation of colorectal cancer to angiogenesis inhibitors 116
Different point mutations in the met oncogene elicit distinct biological properties. 111
Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacy 108
Expression and Functional Regulation of Myoglobin in Epithelial Cancers 103
Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists. 102
MET(PRC) mutations in the Ron receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential. 96
A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met 91
Tivantinib (ARQ197) Displays Cytotoxic Activity That Is Independent of Its Ability to Bind MET 87
An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity. 84
Monovalency unleashes the full therapeutic potential of the DN-30 anti-Met antibody 83
Prevention of hypoxia by myoglobin expression in human tumor cells promotes differentiation and inhibits metastasis 77
An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice 76
Magic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis 73
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. 70
Targeted anticancer therapy by a recombinant monovalent antibody against the MET oncogene 67
A novel dual specificity phosphatase induced by serum stimulation and heat shock. 67
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor 66
Antibody Fragments, Compositions And Uses Thereof - granted patent (USA) 66
Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells. 65
Mutations in the met oncogene unveil a 'dual switch' mechanism controlling tyrosine kinase activity. 64
HGF-MSP chimera protects kidneys from ischemia-reperfusion injury. 61
A Mesenchymal-epithelial transition factor-Agonistic Antibody Accelerates Cirrhotic Liver Regeneration and Improves Mouse Survival Following Partial Hepatectomy 61
Anti C-met Antibodies - granted patent (Canada) 60
A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1. 56
Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. 55
ANTI-MET ANTIBODIES AND USES THEREOF 49
Hypoxia, angiogenesis and cancer therapy: to breathe or not to breathe? 47
HGF-MET AGONIST FOR USE IN THE TREATMENT OF CANCER AND COLORECTAL FIBROSIS 47
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis 46
Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET--response. 45
HIGH AFFINITY BINDING SITE OF HGFR AND METHODS FOR IDENTIFICATION OF ANTAGONISTS THEREOF 45
New antibody fragments, compositions and uses thereof 44
Targeted therapies: Tivantinib-a cytotoxic drug in MET inhibitor's clothes? 43
New Antibody Fragments, Compositions And Uses Thereof - granted patent (Eurasian Patent Organisation) 43
RECOMBINANT PROTEINS DERIVED FROM HGF AND MSP 41
The insulin receptor substrate-1-related 4PS substrate but not the interleukin-2R gamma chain is involved in interleukin-13-mediated signal transduction. 40
New Antibody Fragments, Compositions And Uses Thereof - granted patent (Canada) 37
METHODS FOR PROMOTING PANCREATIC ISLET CELL GROWTH 37
MAGIC-FACTOR, A PARTIAL AGONIST OF MET, ACTS AS A SAFE HEPATOTROPHIC CYTOKINE 36
Molecular cloning, sequencing, chromosomal localization and expression of mouse p21 (Waf1). 33
p53 functional impairment and high p21waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cells. 32
Stimulation of the platelet-derived growth factor beta receptor signaling pathway activates protein kinase C-delta. 31
Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells. 31
TaqI RFLP of the human tropomyosin gene (TPM3) involved in the generation of the TRK oncogene. 31
Induction of WAF1/CIP1 by a p53-independent pathway. 29
The nhance® mutation-equipped anti-met antibody argx-111 displays increased tissue penetration and anti-tumor activity in advanced cancer patients 24
Correction: Magic-Factor 1, a Partial Agonist of Met, Induces Muscle Hypertrophy by Protecting Myogenic Progenitors from Apoptosis 16
Microscope-Based Automated Quantification of Liver Fibrosis in Mice Using a Deep Learning Algorithm 16
Totale 4.020
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.612
article - articoli 0
book - libri 0
conference - conferenze 486
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.098
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020318 0 0 0 0 30 99 64 23 27 31 31 13
2020/2021378 20 8 13 21 32 18 53 15 35 46 19 98
2021/2022669 63 51 33 63 14 15 17 23 24 40 212 114
2022/2023808 85 53 17 70 62 231 71 67 83 9 44 16
2023/2024390 43 59 22 24 23 54 6 14 2 24 71 48
2024/2025463 7 49 37 99 271 0 0 0 0 0 0 0
Totale 4.020